Atherosclerosis and Hyperlipidemia

Lale Tokgözoğlu, Kausik Ray, Ulrich Laufs, et al

Watch time: 1h 24m 9s (5 videos)

Kausik Ray,

Watch time: 1m 43s

Julia Brandts,

Watch time: 1m 44s

Marinela Beznă , Gabriela Mitoaica , Lorena Ungureanu , et al

Read time: 1 Min
Dietary Sodium Intake and Atherosclerosis

Jonas Wuopio,

Watch time: 3m 1s

Breda Hennessey , Asad Shabbir , Alejandro Travieso , et al

Read time: 23 Mins
ACC 23: Lipid Management & the CLEAR Trial with Dr Michos

Erin D Michos,

Watch time: 5m 34s
View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 36s
ACC 23: MK-0616: Oral PCSK9 inhibitor In Hypercholesterolemia Patients

Christie Ballantyne,

Watch time: 3m 44s
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Listen time: 22m 4s

Jean-Claude Tardif,

Watch time: 1h 4m 5s (13 videos)

Heather Currie , Christine Williams ,

Edward T Carreras , Donna M Polk ,

Hans-Willi Breuer ,

FOURIER-OLE: Implications for Real-World Practice

Robert P Giugliano,

Watch time: 2m 56s
FOURIER-OLE: Long-term Safety of Evolocumab Therapy in Patients with Evident ASCVD

Michelle O'Donoghue,

Watch time: 3m 30s

Ahmet Fuat, Jim Moore, Gary Ford, et al

Watch time: 1h 35m (4 videos)

Alberto Lorenzatti , Peter P Toth ,

Ewa Dembowski , Michael H Davidson ,

Sumanth Khadke , Jovana Vidovic , Vinod Patel ,

Zsolt Piroth, Hitoshi Matsuo, Evald Høj Christiansen, et al

Sergio Fazio ,

Media

ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s

Ahmet Fuat, Gary Ford, Kausik Ray, et al

Radcliffe & CardioNerds @AHA22: Reduction of Lp(a) With Small Interfering RNA

Gurleen Kaur, Michelle O'Donoghue,

Watch time: 14m 28s
Radcliffe & CardioNerds @AHA22: Reduction of Triglycerides With Pemafibrate

Aruna D Pradhan, Gurleen Kaur,

Watch time: 14m 20s
FOURIER-OLE: Implications for Real-World Practice

Robert P Giugliano,

Watch time: 2m 56s
FOURIER-OLE: The Trial in Context

Marc S Sabatine,

Watch time: 3m 24s
FOURIER-OLE: Long-term Safety of Evolocumab Therapy in Patients with Evident ASCVD

Michelle O'Donoghue,

Watch time: 3m 30s

Paresh Parmar,

Watch time: 1h 7m 2s (4 videos)

Prof Lale Tokgozoglu, Kausik Ray, Maciej Banach, et al

Watch time: 1h 26m 14s (4 videos)

Jean-Claude Tardif,

Watch time: 1h 4m 5s (13 videos)

Maciej Banach, Yassir Javaid, Lale Tokgözoğlu, et al

Watch time: 1:27:02
ACC 2022 Late-breaker Discussion: The SuperWIN Trial

Dylan L Steen, Harriette Van Spall,

Watch time: 16m 57s

Zsolt Piroth, Hitoshi Matsuo, Evald Høj Christiansen, et al

Barbara Stähli , Stephan Kische, Tommaso Gori, et al

ACC 2021: Findings From the RESCUE Trial

Paul M Ridker,

Watch time: 9m 28s
AHA 2020: Findings from the THALES trial — Prof Pierre Amarenco

Pierre Amarenco,

Watch time: 10m 34s
ESC 2020: Final Results of the EVAPORATE Trial

Matthew J Budoff,

Watch time: 7m 48s

Media

Lale Tokgözoğlu, Kausik Ray, Ulrich Laufs, et al

Watch time: 1h 24m 9s (5 videos)

Kausik Ray,

Watch time: 1m 43s

Julia Brandts,

Watch time: 1m 44s
Dietary Sodium Intake and Atherosclerosis

Jonas Wuopio,

Watch time: 3m 1s
ACC 23: Lipid Management & the CLEAR Trial with Dr Michos

Erin D Michos,

Watch time: 5m 34s
View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 36s
ACC 23: MK-0616: Oral PCSK9 inhibitor In Hypercholesterolemia Patients

Christie Ballantyne,

Watch time: 3m 44s
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Listen time: 22m 4s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s

Ahmet Fuat, Jim Moore, Gary Ford, et al

Watch time: 1h 35m (4 videos)

Ahmet Fuat, Gary Ford, Kausik Ray, et al

AHA 22: RESPECT EPA: Eicosapentaenoic Acid for Prevention of Coronary Artery Disease

Hiroyuki Daida, Saahil A Jumkhawala,

Watch time: 14m 14s
Radcliffe & CardioNerds @AHA22: Reduction of Lp(a) With Small Interfering RNA

Gurleen Kaur, Michelle O'Donoghue,

Watch time: 14m 28s
Radcliffe & CardioNerds @AHA22: Reduction of Triglycerides With Pemafibrate

Aruna D Pradhan, Gurleen Kaur,

Watch time: 14m 20s
EP 78: Your Guide to Lipoprotein(a) with Dr. Salim S Virani

Salim S Virani, Ankur Kalra,

Listen time: 46m 28s
FOURIER-OLE: Implications for Real-World Practice

Robert P Giugliano,

Watch time: 2m 56s
FOURIER-OLE: The Trial in Context

Marc S Sabatine,

Watch time: 3m 24s
FOURIER-OLE: Long-term Safety of Evolocumab Therapy in Patients with Evident ASCVD

Michelle O'Donoghue,

Watch time: 3m 30s
ESC 22: 18F-NaF PET for Vulnerable Coronary Plaque imaging After MI

David Newby,

Watch time: 3m 22s

Paresh Parmar,

Watch time: 1h 7m 2s (4 videos)

Prof Lale Tokgozoglu, Kausik Ray, Maciej Banach, et al

Watch time: 1h 26m 14s (4 videos)

Juan Carlos Kaski, Aernoud Fiolet,

Listen time: 7m 25s

Juan-Pablo Kaski, Peter Libby,

Listen time: 6m 42s

Juan Carlos Kaski, Lina Badimon,

Listen time: 8m 39s
Targeting Inflammation in Atherosclerosis: Inflammatory Signalling in Atherosclerosis and CKD

Juan Carlos Kaski, Paul M Ridker,

Listen time: 8m 36s
Targeting Inflammation in Atherosclerosis: Unmet Clinical Needs in Atherosclerosis and Chronic Kidney Disease

Juan Carlos Kaski, Paul M Ridker,

Listen time: 9m 50s

Jean-Claude Tardif,

Listen time: 5m 13s
Targeting Inflammation in Atherosclerosis: LoDoCo2 Trial

Aernoud Fiolet,

Listen time: 5m 3s

Articles

Statin Therapy and the Assessment of Hepatoprotection in Patients with Dyslipidaemia

Marinela Beznă

,

Gabriela Mitoaica

,

Lorena Ungureanu

,

Maria Cristina Beznă

,

Published:

25 April 2023

Citation:

European Cardiology Review 2023;18:e22.

DOI:

https://doi.org/10.15420/ecr.2023.18.PO5
  • Views: Views 36
  • Downloads: Downloads 3
  • Read time: 1 Min

Innovations in Ultra-low Contrast PCI

Breda Hennessey

,

Asad Shabbir

,

Alejandro Travieso

,

Nieves Gonzalo

,

Javier Escaned

,

Published:

29 March 2023

Citation:

Interventional Cardiology 2023;18:e09.

DOI:

https://doi.org/10.15420/icr.2022.32
  • Views: Views 747
  • Downloads: Downloads 70
  • Read time: 23 Mins

Sex Differences in Calcified Coronary Lesions

Sean Fitzgerald

,

Maria Rubini Gimenez

,

Abdelhakim Allali

,

Ralph Toelg

,

Dmitriy S. Sulimov

,

Volker Geist

,

Adnan Kastrati

,

Holger Thiele

,

Gert Richardt

,

Mohamed Abdel-Wahab

,

Published:

20 January 2023

Citation:

Interventional Cardiology 2023;18:e02.

DOI:

https://doi.org/10.15420/icr.2022.07
  • Views: Views 332
  • Downloads: Downloads 26
  • Read time: 17 Mins

Lipoprotein(a) and Cardiovascular Disease

Yoshiyasu Minami

,

Daisuke Kinoshita

,

Yusuke Muramatsu

,

Takako Nagata

,

Junya Ako

,

Published:

13 May 2022

Citation:

Journal of Asian Pacific Society of Cardiology 2022;1:e11.

DOI:

https://doi.org/10.15420/japsc.2021.31
  • Views: Views 1297
  • Downloads: Downloads 63